Plasminogen activator inhibitor 1 (PAI-1), a fibrinolysis inhibitor, is implicated in many age-related metabolic disorders and cancer [65], and PAI-1 levels significantly increase with age, predisposing elderly individuals to cardiovascular complications resulting from thrombosis and atherosclerosis [66]. This evidence concerns the gene SERPINE1 and atherosclerosis.